The mechanism of action of IL-6 may have been through a decrease in the activity of TNFa, a potent osteoclastogenic cytokine that is known to be central to the pathogenesis of RA, and an increase in OPG, leading to decreased osteoclast formation and activity. Here, TNF is linked to rheumatoid arthritis.